Isolation and characterization of a novel bacteriophage ω4D lytic against Enterococcus faecalis strains

Current Microbiology

Volumn 65, Issue 3, 2012, Pages 284-289

  Parasion, Sylwia ^a   Kwiatek, Magdalena ^a   Mizak, Lidia ^a   Gryko, Romuald ^a   Bartoszcze, Michal ^a   Kocik, Janusz ^a  

^a MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE; BACTERIOPHAGE DNA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIOPHAGE ISOLATION; BACTERIOPHAGE PHI 4D; BACTERIUM CULTURE; BACTERIUM EXAMINATION; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; HOST RANGE; MICROBIAL MORPHOLOGY; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PULSED FIELD GEL ELECTROPHORESIS; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIOPHAGES; DNA, VIRAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; SEWAGE; VIRAL PLAQUE ASSAY; VIRAL PROTEINS; VIRION;

ENTEROCOCCUS FAECALIS; MYOVIRIDAE;

EID: 84865961569     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-012-0158-8     Document Type: Article

References (34)

1. Ackermann HW (1998) Tailed bacteriophages: the order caudovirales. Adv Virus Res 51:135-201
2. Araoka H, Kimura M, Yoneyama A (2011) A surveillance of high-level gentamicin-resistant enterococcal bacteremia. J Infect Chemother 17:433-434. doi:10.1007/s10156-010-0175-0
3. Ben Omar N, Castro A, Lucas R et al (2004) Functional and safety aspects of Enterococci isolated from different Spanish foods. Syst Appl Microbiol 27:118-130
4. Biswas B, Adhya S, Washart P et al (2002) Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70:204-210
5. Bonten MJ, Willems R, Weinstein RA (2001) Vancomycinresistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 1:314-325
6. Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin Microbiol Rev 13:686-707
7. Chang HC, Chen CR, Lin JW et al (2005) Isolation and characterization of novel giant Stenotrophomonas maltophilia phage ωSMA5. Appl Environ Microbiol 71:1387-1393
8. Clokie MRJ, Kropinski AM (2009) Bacteriophages: methods and protocols, molecular and applied aspects vol 1 and 2. Humana Press, Totowa, NJ
9. Duckworth DH, Gulig PA (2002) Bacteriophages: potential treatment for bacterial infections. BioDrugs 16:57-62
10. Dworniczek E, Kuzko K, Mróz E (2003) Virulence factors and in vitro adherence of Enterococcus strains to urinary catheters. Folia Microbiol 48:671-678
11. Dzidic S, Bedekovic V (2003) Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 24:519-526
12. Fard RMN, Barton MD, Arthur JL et al (2010) Whole-genome sequencing and gene mapping of a newly isolated lytic enterococcal bacteriophage EFRM31. Arch Virol 155:1887-1891
13. Fard RMN, Barton MD, Heuzenroeder MW (2010) Novel bacteriophages in Enterococcus spp. Curr Microbiol 60:400-406
14. Gachechiladze KK, Balardshishvili NS, Adamia RS (1991) Hostcontrolled modification and restriction as a criterion of evaluating the therapeutical potential of Pseudomonas phage. J Basic Microbiol 31:101-106
15. Gutiérrez D, Martínez B, Rodríguez A et al (2010) Isolation and characterization of bacteriophages infecting Staphylococcus pidermidis. Curr Microbiol 61:601-608
16. Heintz BH, Halilovic J, Christensen CL (2010) Vancomycinresistant enterococcal urinary tract infections. Pharmacotherapy 30:1136-1149
17. Jensen EC, Schrader HS, Rieland B et al (1998) Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl Environ Microbiol 64:575-580
18. Kayser FH (2003) Safety aspects of enterococci from the medical point of view. Int J Food Microbiol 88(2-3):255-262
19. Kropinski AM (2006) Phage therapy. Everything old is new again. Can J Infect Dis Med Microbiol 17:297-306
20. Letkiewicz S, Miedzyborski R, Fortuna W et al (2010) Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis -case report. Folia Microbiol 54:457-461
21. Ma YL, Lu CP (2008) Isolation and identification of a bacteriophage capable of infecting Streptococcus suis type 2 strains. Vet Microbiol 132:340-347
22. Maek W, Wdowiak-Wróbel S, Bartosik M et al (2009) Characterization of phages virulent for Robinia pseudoacacia Rhizobia. Curr Microbiol 59:187-192
23. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B et al (2007) Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Post Hig Med Dośw 61:461-465
24. Paisano AF, Spira B, Cai S et al (2004) In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212. Oral Microbiol Immunol 19:327-330
25. Ramírez B, Centrón D, Ramírez MS et al (2006) Isolation and characterization of lytic bacteriophages of Enterococcus spp. Int Congr Ser 1289:162-164. doi:10.1016/j.ics.2005.09.111
26. Reik R, Tenover FC, Klein E et al (2008) The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 62:81-85
27. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
28. Shevchenko A, Wilm M, Vorm O et al (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68:850-858
29. Son JS, Jun SY, Kim EB et al (2009) Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1. J Appl Microbiol. doi:10.1111/j.1365-2672. 2009.04576.x
30. Uchiyama J, Rashel M, Maeda Y et al (2007) Isolation and characterization of a novel Enterococcus faecalis bacteriophage uEF24C as a therapeutic candidate. FEMS Microbiol Lett 278:200-206
31. Uchiyama J, Rashel M, Takemura I et al (2008) In silico and in vivo evaluation of bacteriophage uEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl Environ Microbiol 74:4149-4163
32. Uchiyama J, Takemura I, Hayashi I et al (2011) Characterization of lytic enzyme Open Reading Frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage uEF24C. Appl Environ Microbiol 77:580-585
33. Vinodkumar CS, Srinivasa H, Basavarajappa KG et al (2011) Isolation of bacteriophages to multi-drug resistant Enterococci obtained from diabetic foot: a novel antimicrobial agent waiting in the shelf. Indian J Pathol Microbiol 1:90-95
34. Yang H, Liang L, Lin S et al (2010) Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 10:131 http://www.biomedcentral.com/1471-2180/10/131